Who are Output Labs's investors?

Output Labs's investors include Able Partners, Great Oaks Venture Capital, Icebook Investments Corp., Olive Tree Capital, Y Combinator, Calibrate Ventures, First Round Capital, Friale and 6 more.

Where is Output Labs headquartered?

Output Labs is headquartered in New York City, US.

Output Labs

YC S21

New York City, US · Founded 2021 · 8 employees · Hiring · 14 known investors

Find your way into Output Labs

Paths you didn't know you had: your email and LinkedIn already hold routes to the Output Labs team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Output builds generative AI models trained on biological data to discover and develop medicines. The company focuses on applying large biological models to improve diagnosis, treatment, and disease prevention.

Also known as Jingu Health Inc. · Jingu Health · Output Biosciences

AI & Machine Learning Biotech Healthtech Medical Devices AI-powered Drug Discovery Artificial Intelligence Generative AIUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S21)

Adi Mashiach, MD

Mirella Mashiach

Ethan JonesHead of Biologyformer

Matt SingerTechnical Recruiterformer

Nicole NagelRecruiterformer

Zach WalterRecruiterformer

Drew CauthornHead of Talentformer

Investors · 14

Able Partnerslisted by Able PartnersNew York · $500K – $3M

How we know: Y Combinator's founder network · Not right? Tell us

Great Oaks Venture Capitallisted by Great Oaks Venture CapitalNew York · $50K – $500K

How we know: Great Oaks Venture Capital's portfolio page · Y Combinator's founder network · Not right? Tell us

Icebook Investments Corp.listed by Icebook Investments Corp.Calgary

How we know: Icebook Investments Corp.'s portfolio page · Y Combinator's founder network · Not right? Tell us

Olive Tree Capitallisted by Olive Tree CapitalBoston

How we know: Olive Tree Capital's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · Not right? Tell us

Calibrate VenturesreportedPasadena · $5M

How we know: Y Combinator's founder network · Not right? Tell us

First Round CapitalreportedSan Francisco · $100K – $20M

How we know: Y Combinator's founder network · Not right? Tell us

FrialereportedNashville · $100K – $600K

How we know: Y Combinator's founder network · Not right? Tell us

Green Cow Venture CapitalreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Hustle FundreportedSan Carlos · $150K

How we know: Y Combinator's founder network · Not right? Tell us

ImmeasurablereportedLos Angeles · $25K – $100K

How we know: Y Combinator's founder network · Not right? Tell us

Julian Shapiroreported

How we know: Y Combinator's founder network · Not right? Tell us

Lerer HippeaureportedNew York · $500K – $2M

How we know: Y Combinator's founder network · Not right? Tell us

Mesia Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 10

Actio Biosciences, Inc.Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.

WonderTxWonderTx is an AI-native biotech that develops extrapolative AI models to discover oral drug molecules for targets with validated human biology that currently lack a viable pill-based treatment. The company aims to convert injectable therapies into pills and works on both its own and partner drug discovery programs.

Diffuse BioDiffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.

VaiaVaia is a learning app that gives students AI-generated explanations, flashcards, notes, mock exams, and study sets, along with study modes like spaced repetition. It serves students preparing for exams, offering tools to create and organize learning materials across phone, tablet, and laptop.

Ångström AIÅngström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.

Generate BiomedicinesGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.

Evolvere BioSciencesEvolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

Rosebud BiosciencesRosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.

Ditto BiosciencesDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.

AviadoBioAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.

Companies working in the same space as Output Labs.

Legal entities · 1

corporate structure

Jingu Health Inc.

Frequently asked questions

What does Output Labs do?: Output builds generative AI models trained on biological data to discover and develop medicines. The company focuses on applying large biological models to improve diagnosis, treatment, and disease prevention.
Who are Output Labs's investors?: Output Labs's investors include Able Partners, Great Oaks Venture Capital, Icebook Investments Corp., Olive Tree Capital, Y Combinator, Calibrate Ventures, First Round Capital, Friale and 6 more.
Where is Output Labs headquartered?: Output Labs is headquartered in New York City, US.